The hope for affordable insulin

Dong Lyu writes for Bloomberg about the Access to Medicine Foundation's report that looks at how pharmaceutical companies can scale up access to insulin in low- and middle-income countries. 

Dong interviewed Jay Iyer, our CEO:

"A lot of companies always have the US-and-Europe first mentality. That makes a chronic problem even more exacerbated."